ANN logo

Ansell Limited Stock Price

ASX:ANN Community·AU$4.0b Market Cap
  • 2 Narratives written by author
  • 0 Comments on narratives written by author
  • 45 Fair Values set on narratives written by author

ANN Share Price Performance

AU$28.08
-5.68 (-16.82%)
AU$34.10
Fair Value
AU$28.08
-5.68 (-16.82%)
17.7% undervalued intrinsic discount
AU$34.10
Fair Value
Price AU$28.08
reyyyyy AU$34.10
AnalystConsensusTarget AU$36.47

ANN Community Narratives

reyyyyy·
Fair Value AU$34.1 17.7% undervalued intrinsic discount

Overweight on ANN

1users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
AnalystConsensusTarget·
Fair Value AU$36.47 23.0% undervalued intrinsic discount

Healthcare And PPE Market Potential Will Support Greater Share Price Upside

0users have liked this narrative
0users have commented on this narrative
24users have followed this narrative
ANN logo
Ansell

Overweight on ANN

My view: Ansell (ASX: ANN) is a quality, mid-risk company suited for a long-term investment. It operates within a stable and expanding TAM, supported by rising global safety and healthcare demand.Read more

View narrative
29
users have viewed this narrative
1users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
AU$34.1
17.7% undervalued intrinsic discount
Fair Value
Revenue
8.95% p.a.
Profit Margin
6.74%
Future PE
22.41x
Price in 2031
AU$50.18
AU$36.47
23.0% undervalued intrinsic discount
Revenue
4.18% p.a.
Profit Margin
10.89%
Future PE
17.73x
Price in 2029
AU$45.88

Trending Discussion

Updated Narratives

ANN logo

Overweight on ANN

Fair Value: AU$34.1 17.7% undervalued intrinsic discount
3 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
ANN logo

ANN: Sustainable Chemical Protection And Capital Returns Will Support Future Margin And Pricing Power

Fair Value: AU$36.47 23.0% undervalued intrinsic discount
24 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Very undervalued with excellent balance sheet.

1 Risk
5 Rewards

Ansell Limited Key Details

US$2.0b

Revenue

US$1.2b

Cost of Revenue

US$847.5m

Gross Profit

US$712.1m

Other Expenses

US$135.4m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Aug 25, 2026
0.96
42.16%
6.74%
36.6%
View Full Analysis

About ANN

Founded
1893
Employees
15000
CEO
Nathalie Ahlstrom
WebsiteView website
www.ansell.com

Ansell Limited designs, sources, develops, manufactures, distributes, and sells hand and body protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. It operates through two segments: Healthcare and Industrial. The Healthcare segment manufactures and markets solutions, including surgical gloves, single-use and examination gloves, and clean and sterile gloves and garments, as well as consumables for hospitals, surgical centers, dental surgeries, veterinary clinics, first responders, manufacturers, auto repair shops, chemical plants, laboratories, and life sciences and pharmaceutical companies. The Industrial segment manufactures and markets hand and chemical protective clothing solutions for various industrial applications, including automotive, chemical, metal fabrication, machinery and equipment, food, construction, mining, oil and gas, utilities, logistics, and first responders. It sells provides its products under ActivArmr, AlphaTec, BioClean, EDGE, ENCORE, GAMMEX, HyFlex, Kimtech, KleenGuard, MICROFLEX, MICRO-TOUCH, RINGERS, SANDEL, TouchNTuff, and VIKING brands. The company was formerly known as Pacific Dunlop Limited and changed its name to Ansell Limited in 2002. Ansell Limited was founded in 1893 and is based in Richmond, Australia.